Regenxbio Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
RGNX Nasdaq 8731 https://regenxbio.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Regenxbio Inc

REGENXBIO to Participate in Chardan's 8th Annual Genetic Medicines Conference - Sep 23rd, 2024 8:05 pm
REGENXBIO Appoints Mitchell Chan as Chief Financial Officer - Sep 17th, 2024 11:05 am
RegenxBio touts positive data for rare disease drug RGX-121 - Sep 3rd, 2024 5:33 pm
REGENXBIO Announces Positive Data from Pivotal Dose Level of RGX-121 Demonstrating Long-Term Systemic Effect - Sep 3rd, 2024 12:04 pm
REGENXBIO to Participate in Upcoming Investor Conferences - Aug 29th, 2024 8:05 pm
REGENXBIO Announces Presentation at the Society for the Study of Inborn Errors of Metabolism (SSIEM) 2024 Annual Symposium - Aug 27th, 2024 11:05 am
REGENXBIO to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference - Aug 8th, 2024 11:05 am
7 Biotech Stocks to Buy for Their Game-Changing Potential - Aug 8th, 2024 10:00 am
Wall Street Analysts Think Regenxbio (RGNX) Could Surge 234.37%: Read This Before Placing a Bet - Aug 6th, 2024 1:55 pm
REGENXBIO Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Aug 3rd, 2024 12:43 pm
Regenxbio (RGNX) Reports Q2 Loss, Tops Revenue Estimates - Aug 1st, 2024 9:45 pm
Regenxbio: Q2 Earnings Snapshot - Aug 1st, 2024 8:46 pm
REGENXBIO Reports Second Quarter 2024 Financial Results and Recent Operational Highlights - Aug 1st, 2024 8:05 pm
REGENXBIO ANNOUNCES NEW POSITIVE DATA FROM AFFINITY DUCHENNE® TRIAL OF RGX-202 - Aug 1st, 2024 11:03 am
Insider Sale: CEO Curran Simpson Sells Shares of Regenxbio Inc (RGNX) - Jul 30th, 2024 11:01 pm
REGENXBIO to Host Conference Call on August 1 to Discuss Second Quarter 2024 Financial Results and Recent Operational Highlights - Jul 25th, 2024 11:05 am
Regenxbio (RGNX) Surges 18.3%: Is This an Indication of Further Gains? - Jul 12th, 2024 1:59 pm
Here's Why Sarepta (SRPT) Stock Price Surged 57% YTD - Jul 8th, 2024 4:04 pm
Why Did Analysts Maintain a Bullish Stance on REGENXBIO Inc. (RGNX) Despite Decline In Its Revenue Growth? - Jun 27th, 2024 2:05 pm
Regenxbio (RGNX) Soars 6.4%: Is Further Upside Left in the Stock? - Jun 25th, 2024 8:32 am